Steve Cohen sold Aptevo Therapeutics Inc (NASDAQ: APVO)
Steve Cohen (D-TN), a U.S. Representative, has disclosed 1 trade in Aptevo Therapeutics Inc (APVO) since 2019, a single sale, worth an estimated $285 in disclosed volume (the midpoint of the dollar ranges members report, not exact amounts).
The trade highlighted here is a sale: Steve Cohen sold $470.99 of Aptevo Therapeutics Inc (NASDAQ: APVO) on June 24, 2019. Since that trade, APVO is down -100.00% against the S&P 500 up +174.44%, an outperformance of -274.44%.
Data updated
Steve Cohen's APVO trades vs the price
APVO is down -100.00% since Steve Cohen sold on June 24, 2019, versus +174.44% for the S&P 500.
Performance since this trade
All Steve Cohen APVO trades
Steve Cohen & APVO trading FAQ
Is it legal for Steve Cohen to trade Aptevo Therapeutics Inc (APVO) stock?
Yes. Members of Congress are allowed to trade individual stocks, including Aptevo Therapeutics Inc (APVO), but the STOCK Act of 2012 requires them to publicly disclose each transaction within 45 days. Quantellect tracks those disclosures; this page does not imply the trade was improper.
When did Steve Cohen sell APVO?
Steve Cohen disclosed a sale of $470.99 of Aptevo Therapeutics Inc (APVO) on June 24, 2019, according to public STOCK Act filings.
How has APVO performed since Steve Cohen's trade?
Since Steve Cohen sold APVO on June 24, 2019, the stock is down -100.00%, versus +174.44% for the S&P 500 over the same period, an outperformance of -274.44%.
How soon must members of Congress disclose a trade?
Under the STOCK Act, members of Congress must publicly report a covered transaction within 45 days of the trade. Filings can still be delayed, amended, or contain errors.
Where can I see all congressional APVO trades?
Quantellect tracks every disclosed congressional trade in Aptevo Therapeutics Inc (APVO) on the Aptevo Therapeutics Inc congressional trading page, which aggregates filings across all members of Congress.
Steve Cohen's APVO tradesAll congressional filings for Aptevo Therapeutics IncSteve Cohen's full profile
Not investment advice. Congressional trading data is sourced from public STOCK Act disclosures, which are filed with a delay and may contain errors or be revised. Estimated prices and post-trade returns are derived algorithmically from public filings and end-of-day market data and describe historical activity, not a recommendation. Always do your own research and consult a licensed financial advisor before making investment decisions.